0000310764-22-000116.txt : 20221205 0000310764-22-000116.hdr.sgml : 20221205 20221205190952 ACCESSION NUMBER: 0000310764-22-000116 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20221202 FILED AS OF DATE: 20221205 DATE AS OF CHANGE: 20221205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lobo Kevin CENTRAL INDEX KEY: 0001519419 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13149 FILM NUMBER: 221446294 MAIL ADDRESS: STREET 1: STRYKER STREET 2: 2825 AIRVIEW BOULEVARD CITY: KALAMAZOO STATE: MI ZIP: 49002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: STRYKER CORP CENTRAL INDEX KEY: 0000310764 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 381239739 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2825 AIRVIEW BLVD CITY: KALAMAZOO STATE: MI ZIP: 49002 BUSINESS PHONE: 2693892600 MAIL ADDRESS: STREET 1: 2825 AIRVIEW BLVD CITY: KALAMAZOO STATE: MI ZIP: 49002 4 1 wf-form4_167028536673114.xml FORM 4 X0306 4 2022-12-02 0 0000310764 STRYKER CORP SYK 0001519419 Lobo Kevin 2825 AIRVIEW BLVD KALAMAZOO MI 49002 1 1 0 0 Chair and CEO Common Stock 2022-12-02 4 M 0 187470 64.01 A 268240 D Common Stock 2022-12-02 4 F 0 120238 240.77 D 148002 D Common Stock 2022-12-02 4 S 0 43809 239.4264 D 104193 D Common Stock 2022-12-02 4 S 0 23423 240.16 D 80770 D Common Stock 632 I By 401K Employee Stock Option granted 02/13/2013 (right to buy) 64.01 2022-12-02 4 M 0 187470 64.01 D 2023-02-12 Common Stock 187470.0 0 D Includes 2,467 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of September 30, 2022, the date of the latest available statement of the reporting person's ESPP holdings. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $239.00 to $239.925, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $240.015 to $240.36, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Exhibit 24, Power of Attorney, is attached. /s/ Lauren E Keller, attorney-in-fact for Kevin A Lobo 2022-12-05 EX-24 2 stryker-powerofattorneyfor.htm POWER OF ATTORNEY - K LOBO Document

POWER OF ATTORNEY

Know all by these presents that the undersigned hereby constitutes and appoints each of Austin Y. Ke, J. Andrés Cedrón, Lauren E. Keller and Stephanie M. Swan, or any of them signing individually, and with full power of substitution, the undersigned's true and lawful attorney-in-fact to:

(1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Stryker Corporation (the “Company”), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5, complete and execute any amendment or amendments thereto, and timely file such form with the U.S. Securities and Exchange Commission and any stock exchange or similar authority, including without limitation the filing of a Form ID or any other documents necessary or appropriate to enable the undersigned to file the Forms 3, 4 and 5 electronically with the SEC; and
(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by or for, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 29th day of November, 2022.

/s/ Kevin Lobo             
Kevin Lobo